US$ 25.29
fda tirzepatide shortage update says of GLP-1 is over Semaglutide and Tirzepatide off FDA
Description
GLP-1 receptor agonist drugs were originally developed to treat type-2 diabetes

By focusing on key aspects of administration and patient education, healthcare providers can help maximize the medication's efficacy

Hypoglycemia: Monitor blood glucose levels closely, especially if using insulin

Orexin (hypoocretin) from hypothalamus and is involved in regulating wakefulness and appetite
They are common and harmless in the syringe, but they take up space that should be occupied by medication, which means you could end up with a slightly lower dose than intended